Latest Articles

  • Diabetes control during Ramadan fasting
    A. V. Raveendran, MBBS, MD and Abdul Hamid Zargar, MBBS, MD, DM
    Cleveland Clinic Journal of Medicine May 2017, 84 (5) 352-356; DOI: https://doi.org/10.3949/ccjm.84a.16073

    For diabetic patients, fasting during Ramadan can cause wide fluctuations in blood sugar levels.

  • In reply: Serotonin syndrome (November 2016)
    Vishal Vashistha, MD, Sukhdeep Kaur, MD, Robert Z. Wang, MD and Gregory Rutecki
    Cleveland Clinic Journal of Medicine May 2017, 84 (5) 342-343; DOI: https://doi.org/10.3949/ccjm.84c.05002
  • Peripartum depression: Early recognition improves outcomes
    Margaret M. Howard, PhD, Niharika D. Mehta, MD and Raymond Powrie, MD
    Cleveland Clinic Journal of Medicine May 2017, 84 (5) 388-396; DOI: https://doi.org/10.3949/ccjm.84a.14060

    Evidence is mounting that the risks of untreated maternal depression outweigh those of treating it.

  • Chronic constipation: Update on management
    Umar Hayat, MD, Mohannad Dugum, MD and Samita Garg, MD
    Cleveland Clinic Journal of Medicine May 2017, 84 (5) 397-408; DOI: https://doi.org/10.3949/ccjm.84a.15141

    If conservative treatments fail, clinicians can choose from a growing list of new ones.

  • Strategies for management of intermittent fasting in patients with diabetes
    Leann Olansky, MD, FACP, FACE
    Cleveland Clinic Journal of Medicine May 2017, 84 (5) 357-358; DOI: https://doi.org/10.3949/ccjm.84a.16118

    The focus is on avoiding hypoglycemia, but patients also need to know the risks of hyperglycemia and ketoacidosis.

  • It’s time to consider pharmacotherapy for obesity
    Derrick C. Cetin, DO
    Cleveland Clinic Journal of Medicine December 2017, 84 (12) 959-960; DOI: https://doi.org/10.3949/ccjm.84a.17077

    Consider using chronic weight-loss medications as adjunctive therapy if lifestyle and behavioral strategies are ineffective.

  • ERAAs for menopause treatment: Welcome the ‘designer estrogens’
    Heather D. Hirsch, MD, MS, NCMP, Elim Shih, MD, NCMP and Holly L. Thacker, MD, NCMP
    Cleveland Clinic Journal of Medicine June 2017, 84 (6) 463-470; DOI: https://doi.org/10.3949/ccjm.84a.15140

    These drugs stimulate estrogen receptors in some tissues and inhibit them in others, enabling tailored treatment.

  • Drug reaction or metastatic lung cancer?
    Hiromichi Hara, MD, PhD, Hirofumi Utsumi, MD, PhD, Hiroshi Wakui, MD, PhD, Haruhiko Yanagisawa, MD, PhD, Mitsuo Hashimoto, MD, PhD and Kazuyoshi Kuwano, MD, PhD
    Cleveland Clinic Journal of Medicine December 2017, 84 (12) 914-915; DOI: https://doi.org/10.3949/ccjm.84a.17005

    Imaging shows nodules randomly distributed throughout both lungs, a paradoxical reaction to drug therapy.

  • Fall risk and anticoagulation for atrial fibrillation in the elderly: A delicate balance
    Tracy Hagerty, MD and Michael W. Rich, MD
    Cleveland Clinic Journal of Medicine January 2017, 84 (1) 35-40; DOI: https://doi.org/10.3949/ccjm.84a.16016

    The decision-making process is complex and should be shared with the patient and the patient’s family and caregivers.

  • To have not and then to have: A challenging immune paradox
    Brian F. Mandell, MD
    Cleveland Clinic Journal of Medicine December 2017, 84 (12) 912-913; DOI: https://doi.org/10.3949/ccjm.84b.12017

    The immune reactivation syndrome can occur when the immune system in an immunosuppressed patient with a partially controlled indolent infection is suddenly normalized.

Pages